Genetics of B Cell Dysfunction

B cells produce antibodies and are critical for adaptive immunity. Genetic variants affecting B cell development, activation, class switching, and memory formation may influence antibody responses to infection and vaccines, and contribute to autoimmune conditions.

This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.

What is B Cell Dysfunction?

B lymphocytes develop in bone marrow, mature in secondary lymphoid organs, and differentiate into plasma cells (antibody secretion) and memory B cells. Key stages include VDJ recombination (RAG1/2), BCR signalling (CD19, CD21, BTK), class switch recombination (AID/AICDA, CD40L/CD154), and plasma cell differentiation (BLIMP1/PRDM1, IRF4). Long COVID patients show altered B cell phenotypes, including increased atypical memory B cells and persistent plasmablasts. Some COVID-19 patients develop autoantibodies recognising interferon pathway components, cytokines, and self antigens — potentially driven by molecular mimicry or bystander activation.

Biological pathways commonly discussed in relation to B Cell Dysfunction

Research into B Lymphocyte Dysfunction and Antibody Deficiency has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.

B Cell Development

B cell development requires RAG1/2-mediated VDJ recombination and successful immunoglobulin heavy and light chain assembly. Deficiency in RAG1, RAG2, or DNTT (TdT) causes severe combined immunodeficiency. Common variants in B cell development genes modulate adaptive immunity efficiency.

Bcr Signalling

B cell receptor (BCR) signalling through CD79A/B, SYK, BTK, and PI3K drives B cell activation, proliferation, and differentiation. Rare BTK mutations cause X-linked agammaglobulinaemia (XLA). Common variants in BCR signalling components affect B cell activation thresholds and autoimmune risk.

Antibody Class Switching

Class switch recombination (CSR) converts IgM to IgG, IgA, or IgE under the direction of AID (AICDA) and T cell help via CD40L-CD40 signalling. AICDA variants affect CSR efficiency and autoimmune risk. IgA deficiency is the most common primary immunodeficiency.

Plasma Cell Differentiation

Plasma cells are terminally differentiated B cells that secrete large quantities of antigen-specific antibody. Differentiation is driven by BLIMP1 (PRDM1) and IRF4, which repress B cell identity genes. Long-lived plasma cells in bone marrow maintain antibody production for decades.

Key genes studied in relation to B Cell Dysfunction

The following genes have been studied in relation to B Lymphocyte Dysfunction and Antibody Deficiency. These genes span the biological pathways most commonly discussed in this area of research.

IKZF3

IKZF3 (Aiolos) is a transcription factor related to IKAROS that regulates B lymphocyte development and differentiation. It is targeted by immunomodulatory drugs and influences plasma cell differentiation.

BCL6

BCL6 is the master transcription factor of germinal center B cells and follicular helper T cells (Tfh). It represses DNA damage checkpoints and alternative differentiation programs to allow affinity maturation of antibodies.

CD19

CD19 is a co-receptor that amplifies B cell receptor signaling in complex with CD21 and CD81. It is a major regulator of B cell activation thresholds and a target of therapies for B cell malignancies and autoimmune diseases.

BTK

BTK is a non-receptor tyrosine kinase essential for B cell receptor signal transduction and mast cell/macrophage activation. It is a therapeutic target for B cell malignancies and autoimmune diseases (ibrutinib).

PLCG2

PLCγ2 is activated by BTK and other tyrosine kinases downstream of immune receptors to generate IP3 and DAG, mobilizing calcium and activating PKC. Gain-of-function variants cause PLCG2-associated antibody deficiency and immune dysregulation (PLAID/APLAID).

SYK

Syk is a tyrosine kinase that transduces signals from B cell receptors, Fc receptors, integrin signaling, and C-type lectin receptors. It is a convergence point for multiple immune activation pathways.

IL21

IL-21 is produced by Tfh and CD4+ T cells to drive B cell differentiation, germinal center reactions, NK cell function, and CD8+ T cell memory formation. It has pleiotropic effects on both innate and adaptive immunity.

CXCR5

CXCR5 is the CXCL13-binding chemokine receptor that guides B cells and Tfh cells into germinal centers and B cell follicles. Its expression marks follicular helper T cells and follicular B cells.

10 genes total studied in relation to B Cell Dysfunction across the ChronicDNA dataset.

Genetic variants commonly discussed

The following genetic variants (SNPs) are found in genes that have been studied in relation to B Cell Dysfunction. Each variant represents a position in the genome where individuals may carry different alleles.

rs2221903IL21 rs4434495CD19 rs145889BCL6 rs2258923AICDA rs6822844IL21 rs1056932BCL6

32 variants total across genes studied in relation to B Cell Dysfunction.

How personal DNA data may provide educational insights

Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as B Cell Dysfunction.

This is not a diagnostic service. Genetic variants do not determine whether you have B Cell Dysfunction, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.

Related conditions and pathways

B Cell Dysfunction shares biological pathways and genetic associations with the following related conditions and areas of research.

Autoimmunity Immune Dysregulation Antibody Response Long Covid Immunodeficiency

Frequently asked questions

How do B cells relate to Long COVID?

Long COVID patients show persistent B cell abnormalities including elevated plasmablasts (antibody-secreting cells), altered memory B cell phenotypes, and autoantibodies targeting interferons, cytokines, and self antigens. These findings suggest ongoing B cell activation and possible molecular mimicry, which may contribute to symptoms.

What are autoantibodies and how do they form after COVID-19?

Autoantibodies are antibodies that bind to self antigens. After COVID-19, autoantibodies targeting IFN-alpha, IFN-omega, ACE2, and numerous other self proteins have been documented. Proposed mechanisms include molecular mimicry (SARS-CoV-2 antigens resembling self), bystander activation, and T cell help dysregulation driving autoreactive B cell responses.

What is common variable immunodeficiency (CVID)?

CVID is the most common symptomatic primary antibody deficiency, characterised by hypogammaglobulinaemia, impaired antibody responses to vaccines, and recurrent infections. It has a complex genetic basis, with TACI (TNFRSF13B), BAFF-R (TNFRSF13C), and NFKB1 variants contributing in subsets of patients.

Which B cell genetics are studied in chronic illness?

Key genes include BTK, CD19, CD79A/B, AICDA, PRDM1, IRF4, TNFRSF13B (TACI), NFKB1, CD40LG, and RAG1/2. These cover B cell development, activation, class switching, plasma cell differentiation, and autoimmune risk.

Explore DNA insights

If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to B Cell Dysfunction and connected biological pathways.

Get Your Personalised DNA Report

Informational and educational only · Not a diagnostic tool · GDPR compliant

10 genes · 32 variants analysed in relation to B Cell Dysfunction